30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Turn Therapeutics Inc (TTRX)

Track

The most recent insider trading activity at Turn Therapeutics Inc. occurred on December 12, 2025. This period saw a total of 9 buy transactions, with a total value of $251,704.36. The majority of these transactions were buys, indicating a net positive sentiment from insiders during this timeframe.
Stock chart
Ticker: TTRX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Chaudhary Zuraiz
See Remarks
1 purchase — total 8,750 USD
Buy 12 Dec 2025
Value US$4,869,563.03 | Price 428.06 | Shares 169
Buy 24 Nov 2025
Value US$4,588,004.34 | Price 446.42 | Shares 8,968
Buy 21 Nov 2025
Value US$58,926.84 | Price 2.87 | Shares 20,532
Buy 21 Nov 2025
Value US$3,290.00 | Price 3.29 | Shares 1,000
Buy 20 Nov 2025
Value US$3,784.50 | Price 2.61 | Shares 1,450
Buy 17 Nov 2025
Value US$9,050.00 | Price 3.62 | Shares 2,500
Buy 23 Oct 2025
Value US$65,715.60 | Price 4.60 | Shares 14,286
Buy 23 Oct 2025
Value US$24,997.50 | Price 4.95 | Shares 5,050
Buy 23 Oct 2025
Value US$99,999.90 | Price 4.95 | Shares 20,202
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-12 2025-12-12 B Purchase
1.9
Chaudhary Zuraiz

See Remarks

Officer
169 -35.8%
428.06
US$4,869,563 		169 -35.8% 428.06 US$4,869,563
2025-11-25 2025-11-24 B Purchase
3.4
GOLDEN ARTHUR F
Non-Executive Director
8,968 +24.2%
446.42
US$4,588,004 		8,968 +24.2% 446.42 US$4,588,004
2025-11-24 2025-11-21 B Purchase
3.4
GOLDEN ARTHUR F
Non-Executive Director
14,908 +22.2%
38.10
US$4,839,736 		14,908 +22.2% 38.10 US$4,839,736
2025-11-21 2025-11-21 B Purchase
1.9
Chaudhary Zuraiz

See Remarks

Officer
1,000 +11.1%
3.29
US$3,290 		1,000 +11.1% 3.29 US$3,290
2025-11-21 2025-11-20 B Purchase
1.9
Chaudhary Zuraiz

See Remarks

Officer
1,450 +19.2%
2.61
US$3,784 		1,450 +19.2% 2.61 US$3,784
2025-11-17 2025-11-17 B Purchase
1.9
Chaudhary Zuraiz

See Remarks

Officer
2,500 +49.5%
3.62
US$9,050 		2,500 +49.5% 3.62 US$9,050
2025-10-29 2025-10-23 B Purchase
1.2
Chesed Abraham
14,286 +1.0%
4.60
US$65,716 		14,286 +1.0% 4.60 US$65,716
2025-10-23 2025-10-23 B Purchase
1.9
Chaudhary Zuraiz

See Remarks

Officer
5,050 +inf%
4.95
US$24,998 		5,050 +inf% 4.95 US$24,998
2025-10-23 2025-10-23 B Purchase
3.4
GOLDEN ARTHUR F
Non-Executive Director
20,202 +202.0%
4.95
US$100,000 		20,202 +202.0% 4.95 US$100,000
Explore more

More insider trading research around Turn Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America